An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Severance Hospital, Seoul, Korea, Republic of
Cleveland Clinic Foundation, Cleveland, Ohio, United States
University of Rochester Medical Center, Rochester, New York, United States
Nationwide Children's Hospital, Columbus, Ohio, United States
National Taiwan University Hospital, anesthesiology department, Taipei, Taiwan
Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada
University of Alberta Hospital, Department of Anesthesiology and Pain Medicine, Edmonton, Alberta, Canada
Red Deer Regional Hospital Centre, Alberta Health Services, Red Deer, Alberta, Canada
Childrens Hospital Los Angeles, Los Angeles, California, United States
Georgia Health Sciences University, Augusta, Georgia, United States
Loyola University Medical Center, Maywood, Illinois, United States
Children's Hospital Boston, Boston, Massachusetts, United States
Austin Hospital, Melbourne, Victoria, Australia
Royal North Shore Hospital, St Leonards, New South Wales, Australia
Royal Perth Hospital, Perth, Western Australia, Australia
ThoraxKärlkliniken, Universitetssjukhuset, Linköping, Sweden
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.